Skip to Content

Straumann Holding AG STMN

Morningstar Rating
CHF 117.80 +2.90 (2.52%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Straumann Starts 2024 on Shaky Ground From Weak US Performance and Uncertainties in Core Markets

Straumann is a global leader in dental implants, a market that is estimated to be worth CHF 5.6 billion. With over 60 years of experience, Straumann is frequently ranked as the most credible and trusted dental implant brand in the world. Today, the leading five companies hold about three quarters of the implant market, with the remaining space shared among several hundred local players.

Price vs Fair Value

STMN is trading at a 560% premium.
Price
CHF 117.80
Fair Value
CHF 375.00
Uncertainty
Medium
1-Star Price
CHF 325.00
5-Star Price
CHF 55.00
Economic Moat
Kksxr
Capital Allocation
Cqphdbvf

Bulls Say, Bears Say

Bulls

Straumann is making strategic acquisitions in high-growth markets.

Bears

Straumann might lose China market share because of volume-based procurement, which would have an adverse impact on more than half of sales in Asia-Pacific.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if STMN is a good fit for your portfolio.

Trading Information

Previous Close Price
CHF 114.90
Day Range
CHF 115.50118.75
52-Week Range
CHF 97.00151.50
Bid/Ask
CHF 0.00 / CHF 118.80
Market Cap
CHF 18.78 Bil
Volume/Avg
379,604 / 347,252

Key Statistics

Price/Earnings (Normalized)
40.90
Price/Sales
7.80
Dividend Yield (Trailing)
0.72%
Dividend Yield (Forward)
0.72%
Total Yield
0.82%

Company Profile

Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company’s core products are dental implants, and it holds roughly one third of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Large Growth
Total Number of Employees
11,100

Competitors

Valuation

Metric
STMN
XRAY
ALGN
Price/Earnings (Normalized)
40.9013.3127.28
Price/Book Value
10.231.584.87
Price/Sales
7.801.324.73
Price/Cash Flow
32.4710.9022.23
Price/Earnings
STMN
XRAY
ALGN

Financial Strength

Metric
STMN
XRAY
ALGN
Quick Ratio
1.340.711.02
Current Ratio
1.951.431.23
Interest Coverage
19.50−0.45
Quick Ratio
STMN
XRAY
ALGN

Profitability

Metric
STMN
XRAY
ALGN
Return on Assets (Normalized)
13.05%5.31%11.78%
Return on Equity (Normalized)
23.67%11.38%19.68%
Return on Invested Capital (Normalized)
18.17%8.02%18.66%
Return on Assets
STMN
XRAY
ALGN
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
GbllzfzlPtsnw$154.2 Bil
Becton Dickinson & Co
BDX
QlhdbnnWpyzxjt$66.1 Bil
Alcon Inc
ALC
HfmtjpzdNdxhvy$44.2 Bil
ResMed Inc
RMD
BnnhkmxzstMdxfnyj$27.8 Bil
Coloplast A/S ADR
CLPBY
QczktbpvVlmd$27.7 Bil
West Pharmaceutical Services Inc
WST
RvltxjxspLzfx$23.5 Bil
Hologic Inc
HOLX
BkzvyxqtFssytn$17.1 Bil
The Cooper Companies Inc
COO
GlhzwtrmVlrddn$17.0 Bil
Baxter International Inc
BAX
TqwddzfKkcqp$16.9 Bil
Teleflex Inc
TFX
LwcJcrl$10.0 Bil

Sponsor Center